Six‐pattern p53 interpretation in 1293 vulvar squamous cell carcinomas: inter‐pathologist variation and pattern distribution according to p16 status
Histopathology · 2025-12 · 87 (6) · 815-826
DOI: 10.1111/his.15561 ↗Kurz gefasst
Fachartikel in der Zeitschrift Histopathology, online erschienen am 18.09.2025. Verfasst von Emma L Kaderly Rasmussen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Danish Cancer Institute, Unit of Virus, Lifestyle and Genes, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Vulvar Neoplasms, Tumor Suppressor Protein p53, Carcinoma, Squamous Cell, Cyclin-Dependent Kinase Inhibitor p16. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Erik og Susanna Olesens Almenvelgørende Fond, Sjællands Universitetshospital, Kræftens Bekæmpelse.
Abstract (Originalsprache)
Aims
Vulvar squamous cell carcinoma (VSCC) is classified into human papillomavirus (HPV)‐associated and HPV‐independent types, primarily using p16 immunohistochemistry, with p53 staining playing a complementary role since a subset of HPV‐independent VSCC is driven by TP53 mutations. We aimed to assess the robustness of the six‐pattern p53 classification by evaluating interobserver agreement and mapping pattern distribution in relation to p16 status.
Methods
We performed p53 immunohistochemistry on 1293 VSCC cases, comprising 832 p16‐negative and 461 p16‐positive cases. Eight pathologists independently evaluated p53, with each case assessed by two pathologists. Expression was classified as wild‐type (scattered or mid‐epithelial) or mutated (basal overexpression, parabasal/diffuse overexpression, absent or cytoplasmic). Interobserver agreement was measured using kappa statistics.
Results
Overall concordance across the six p53 patterns was 66.7%, increasing to 86.9% when dichotomized as wild‐type versus mutated. In the p16‐negative cases, concordance was 68.8% across all six patterns and 82.6% when dichotomized. Corresponding rates in the p16‐positive cases were 62.9% and 94.6%. Kappa values for pairwise assessments ranged from 0.44 to 0.73 (six‐pattern) and from 0.60 to 0.88 (dichotomized). After resolving discordant cases, 79.9% of p16‐negative cases showed a mutated pattern, and 20.1% were wild type (scattered). Among the p16‐positive cases, 93.1% exhibited a wild‐type pattern.
Conclusions
Findings support the clinical robustness of the six‐pattern p53 framework, as interobserver agreement was high and most discrepancies were unlikely to impact tumour classification. While p16 proved helpful in p53 interpretation, certain cases remained challenging due to p53 heterogeneity or ambiguous p16/p53 combinations indicating a need for additional molecular testing in such instances.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Danish Cancer Institute, Unit of Virus, Lifestyle and Genes, Copenhagen, Denmark.
- Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
- Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
- Department of Pathology, Zealand University Hospital, Næstved, Denmark.
- Department of Pathology, Aarhus University Hospital, Aarhus, Denmark.
- Department of Pathology, Hvidovre University Hospital, Hvidovre, Denmark.
ORCID-Profile: Emma L Kaderly Rasmussen, Susanne K Kjær, Alexander K Kjær, Doris Schledermann, Kirsten Frederiksen, Marianne Waldstrøm, Louise Baandrup
Förderung
- Erik og Susanna Olesens Almenvelgørende Fond
- Sjællands Universitetshospital
- Kræftens Bekæmpelse
Zitieren
APA
Kaderly Rasmussen, E. L., Kjær, S. K., Larsen, L. G., Mejlgaard, E., Franzmann, M. B., Kjær, A. K., Salinas, N. V., Schledermann, D., Frederiksen, K., Hansen, T., Winberg, B. H., Waldstrøm, M., & Baandrup, L. (2025). Six‐pattern p53 interpretation in 1293 vulvar squamous cell carcinomas: inter‐pathologist variation and pattern distribution according to p16 status. Histopathology, 87(6), 815-826. https://doi.org/10.1111/his.15561
Vancouver
Kaderly Rasmussen EL, Kjær SK, Larsen LG, Mejlgaard E, Franzmann MB, Kjær AK, et al. Six‐pattern p53 interpretation in 1293 vulvar squamous cell carcinomas: inter‐pathologist variation and pattern distribution according to p16 status. Histopathology. 2025;87(6):815-826. doi:10.1111/his.15561
BibTeX
@article{KaderlyRasmussen2025,
author = {Kaderly Rasmussen, Emma L and Kjær, Susanne K and Larsen, Lise G and Mejlgaard, Else and Franzmann, Maria B and Kjær, Alexander K and Salinas, Nadia V and Schledermann, Doris and Frederiksen, Kirsten and Hansen, Tatiana and Winberg, Birgitte H and Waldstrøm, Marianne and Baandrup, Louise},
title = {Six‐pattern p53 interpretation in 1293 vulvar squamous cell carcinomas: inter‐pathologist variation and pattern distribution according to p16 status},
journal = {Histopathology},
year = {2025},
volume = {87},
number = {6},
pages = {815--826},
doi = {10.1111/his.15561}
}
EUVIMED